Celldex Therapeutics to Present at Upcoming Investor Conferences
Celldex Therapeutics (NASDAQ:CLDX) has announced its management's participation in two upcoming investor conferences. The company will engage in fireside chats at the following events:
- 2024 Cantor Global Healthcare Conference on Tuesday, September 17th at 8:35 a.m. ET
- TD Cowen's Chronic Urticaria Summit on Friday, September 20th at 10:00 a.m. ET
Live webcasts of these presentations will be accessible on the 'Events & Presentations' page of the 'Investors & Media' section on Celldex's website. Replays will remain available for 90 days after each event, providing investors with extended access to the company's insights and updates.
Celldex Therapeutics (NASDAQ:CLDX) ha annunciato la partecipazione della sua direzione a due prossimi eventi dedicati agli investitori. L'azienda prenderà parte a conversazioni informali durante i seguenti eventi:
- 2024 Cantor Global Healthcare Conference il martedì 17 settembre alle 8:35 a.m. ET
- TD Cowen's Chronic Urticaria Summit il venerdì 20 settembre alle 10:00 a.m. ET
Le webcasts dal vivo di queste presentazioni saranno accessibili nella pagina 'Eventi e Presentazioni' nella sezione 'Investitori e Media' del sito web di Celldex. Le registrazioni rimarranno disponibili per 90 giorni dopo ogni evento, offrendo agli investitori un accesso prolungato alle informazioni e agli aggiornamenti dell'azienda.
Celldex Therapeutics (NASDAQ:CLDX) ha anunciado la participación de su dirección en dos próximas conferencias para inversores. La compañía estará involucrada en charlas informales en los siguientes eventos:
- 2024 Cantor Global Healthcare Conference el martes 17 de septiembre a las 8:35 a.m. ET
- TD Cowen's Chronic Urticaria Summit el viernes 20 de septiembre a las 10:00 a.m. ET
Las transmisiones en vivo de estas presentaciones estarán disponibles en la página 'Eventos y Presentaciones' de la sección 'Inversores y Medios' del sitio web de Celldex. Las repeticiones estarán disponibles por 90 días después de cada evento, proporcionando a los inversores un acceso prolongado a las perspectivas y actualizaciones de la compañía.
셀덱스 테라퓨틱스 (NASDAQ:CLDX)는 경영진이 두 개의 투자자 회의에 참여할 것이라고 발표했습니다. 회사는 다음 행사에서 화상 인터뷰를 진행할 예정입니다:
- 2024 칸토 글로벌 헬스케어 컨퍼런스 2023년 9월 17일 화요일 오전 8:35 ET
- TD 코웬의 만성 두드러기 정상 회담 2023년 9월 20일 금요일 오전 10:00 ET
이 발표의 실시간 웹캐스트는 셀덱스 웹사이트의 '투자자 및 미디어' 섹션의 '이벤트 및 프레젠테이션' 페이지에서 접근할 수 있습니다. 각 이벤트 후 90일 동안 재생이 가능하여 투자자들에게 회사의 인사이트와 업데이트에 대한 장기적인 접근을 제공합니다.
Celldex Therapeutics (NASDAQ:CLDX) a annoncé la participation de son équipe de direction à deux prochaines conférences pour investisseurs. L'entreprise participera à des discussions informelles lors des événements suivants :
- 2024 Cantor Global Healthcare Conference le mardi 17 septembre à 8h35 ET
- Sommet sur l'urticaria chronique de TD Cowen le vendredi 20 septembre à 10h00 ET
Les retransmissions en direct de ces présentations seront accessibles sur la page 'Événements & Présentations' de la section 'Investisseurs & Médias' du site de Celldex. Les rediffusions resteront disponibles pendant 90 jours après chaque événement, offrant aux investisseurs un accès prolongé aux insights et mises à jour de l'entreprise.
Celldex Therapeutics (NASDAQ:CLDX) hat die Teilnahme seines Managements an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird an den folgenden Veranstaltungen in persönlichen Gesprächen teilnehmen:
- 2024 Cantor Global Healthcare Conference am Dienstag, den 17. September um 8:35 Uhr ET
- TD Cowens Chronic Urticaria Summit am Freitag, den 20. September um 10:00 Uhr ET
Die Live-Webcasts dieser Präsentationen sind auf der Seite 'Veranstaltungen & Präsentationen' im Bereich 'Investoren & Medien' auf der Website von Celldex zugänglich. Wiederholungen sind für 90 Tage nach jeder Veranstaltung verfügbar, was den Investoren einen längeren Zugang zu den Einblicken und Aktualisierungen des Unternehmens bietet.
- None.
- None.
HAMPTON, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:
2024 Cantor Global Healthcare Conference on Tuesday, September 17th at 8:35 a.m. ET
TD Cowen's Chronic Urticaria Summit on Friday, September 20th at 10:00 a.m. ET
Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. Replays will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com
FAQ
When is Celldex Therapeutics (CLDX) presenting at the 2024 Cantor Global Healthcare Conference?
What time is Celldex Therapeutics (CLDX) participating in TD Cowen's Chronic Urticaria Summit?
Where can investors watch the live webcasts of Celldex Therapeutics (CLDX) presentations?
How long will the replays of Celldex Therapeutics (CLDX) conference presentations be available?
